Published in J Neurol Neurosurg Psychiatry on August 01, 1999
Results of spinal meningioma surgery in patients with severe preoperative neurological deficits. Eur Spine J (2004) 0.91
Cerebrospinal fluid obstruction and malabsorption in human neonatal hydrocephaly. Childs Nerv Syst (2006) 0.85
Delayed Medullar Syndrome after Aneurysmal Subarachnoid Haemorrhage. A Case report of Cystic Arachnoiditis! Interv Neuroradiol (2007) 0.79
Procollagen I C-propeptide in the cerebrospinal fluid of neonates with posthaemorrhagic hydrocephalus. Arch Dis Child Fetal Neonatal Ed (2002) 0.77
Syringomyelia and spinal arachnoiditis resulting from aneurysmal subarachnoid hemorrhage: Report of two cases and review of the literature. J Craniovertebr Junction Spine (2014) 0.77
Study on different surgical approaches for acute Lumber disk protrusion combined with Cauda Equina Syndrome. Int J Clin Exp Pathol (2014) 0.75
Compressive Cervicothoracic Adhesive Arachnoiditis following Aneurysmal Subarachnoid Hemorrhage: A Case Report and Literature Review. J Neurol Surg Rep (2014) 0.75
Procollagen propeptides in chronic subdural hematoma reveal sustained dural collagen synthesis after head injury. J Neurol (2009) 0.75
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg (1968) 6.98
Collagens: molecular biology, diseases, and potentials for therapy. Annu Rev Biochem (1995) 5.52
Grading the amount of blood on computed tomograms after subarachnoid hemorrhage. Stroke (1990) 1.83
Transthyretin: a choroid plexus-specific transport protein in human brain. The 1986 S. Weir Mitchell award. Neurology (1986) 1.78
Gene expression of type I, III and IV collagens in hepatic fibrosis induced by dimethylnitrosamine in the rat. Biochem J (1987) 1.46
Profiles of steady state levels of messenger RNAs coding for type I procollagen, elastin, and fibronectin in hamster lungs undergoing bleomycin-induced interstitial pulmonary fibrosis. J Clin Invest (1985) 1.30
Analysing connective tissue metabolites in human serum. Biochemical, physiological and methodological aspects. J Hepatol (1995) 1.27
Collagen biosynthesis in bleomycin-induced pulmonary fibrosis in hamsters. J Lab Clin Med (1980) 1.15
Localization of collagen alpha 1(I) gene expression during wound healing by in situ hybridization. J Invest Dermatol (1989) 1.12
On the question of a subdural space. Anat Rec (1991) 1.11
Subarachnoid haemorrhage induced proliferation of leptomeningeal cells and deposition of extracellular matrices in the arachnoid granulations and subarachnoid space. Immunhistochemical study. Acta Neurochir (Wien) (1995) 1.09
An ultrastructural and immunocytochemical analysis of leptomeningeal and meningioma cultures. J Neuropathol Exp Neurol (1986) 1.02
Laboratory investigation of cerebrospinal fluid proteins. Ann Clin Biochem (1990) 0.95
Choroid plexus: the major site of mRNA expression for the beta-trace protein (prostaglandin D synthase) in human brain. Neurosci Lett (1996) 0.94
MR imaging of the meninges. Part I. Normal anatomic features and nonneoplastic disease. Radiology (1996) 0.94
Cystatin C and transthyretin expression in normal and neoplastic tissues of the human brain and pituitary. Acta Neuropathol (1997) 0.92
Changes in the subarachnoid space after experimental subarachnoid haemorrhage in the dog: scanning electron microscopic observation. Acta Neurochir (Wien) (1977) 0.87
The distribution of cerebral expression of the transferrin gene is species specific. J Biol Chem (1991) 0.80
Carboxyterminal propeptide of type I procollagen in cerebrospinal fluid in childhood and in children with leukemia undergoing intrathecal treatment. Clin Chem (1991) 0.79
Post-haemorrhagic subarachnoid fibrosis in dogs. Scanning electron microscopic observation and dye perfusion study. Acta Neurochir (Wien) (1979) 0.79
Phylogenetic network for European mtDNA. Am J Hum Genet (2001) 3.26
Demyelinating polyneuropathy in a patient with the tRNA(Leu)(UUR) mutation at base pair 3243 of the mitochondrial DNA. Neurology (1995) 2.05
Partial identity of the 2-oxoglutarate and ascorbate binding sites of prolyl 4-hydroxylase. J Biol Chem (1986) 1.75
A 3-year clinical follow-up of adult patients with 3243A>G in mitochondrial DNA. Neurology (2006) 1.58
The 2-oxoglutarate binding site of prolyl 4-hydroxylase. Identification of distinct subsites and evidence for 2-oxoglutarate decarboxylation in a ligand reaction at the enzyme-bound ferrous ion. Eur J Biochem (1984) 1.56
Ascorbate is consumed stoichiometrically in the uncoupled reactions catalyzed by prolyl 4-hydroxylase and lysyl hydroxylase. J Biol Chem (1984) 1.50
A novel mitochondrial DNA mutation and a mutation in the Notch3 gene in a patient with myopathy and CADASIL. J Mol Med (Berl) (2001) 1.46
Phylogenetic network of the mtDNA haplogroup U in Northern Finland based on sequence analysis of the complete coding region by conformation-sensitive gel electrophoresis. Am J Hum Genet (2000) 1.45
Human mtDNA sublimons resemble rearranged mitochondrial genoms found in pathological states. Hum Mol Genet (2000) 1.37
Treatment for mitochondrial disorders. Cochrane Database Syst Rev (2006) 1.31
Reduction of collagen production in keloid fibroblast cultures by ethyl-3,4-dihydroxybenzoate. Inhibition of prolyl hydroxylase activity as a mechanism of action. J Biol Chem (1987) 1.25
Phylogenetic analysis of mitochondrial DNA in patients with an occipital stroke. Evaluation of mutations by using sequence data on the entire coding region. Mutat Res (2001) 1.18
APP locus duplication in a Finnish family with dementia and intracerebral haemorrhage. J Neurol Neurosurg Psychiatry (2007) 1.17
Evidence for mtDNA admixture between the Finns and the Saami. Hum Hered (2001) 1.16
Differences between collagen hydroxylases and 2-oxoglutarate dehydrogenase in their inhibition by structural analogues of 2-oxoglutarate. Biochem J (1985) 1.13
Partial purification and characterization of chick-embryo prolyl 3-hydroxylase. Biochem J (1979) 1.08
Hereditary dementia with intracerebral hemorrhages and cerebral amyloid angiopathy. Neurology (2004) 1.01
Mitochondrial DNA haplogroup U as a risk factor for occipital stroke in migraine. Lancet (1998) 1.01
Phylogenetic analysis of mtDNA haplogroup TJ in a Finnish population. J Hum Genet (2001) 1.01
Prevalence of large-scale mitochondrial DNA deletions in an adult Finnish population. Neurology (2005) 0.95
Transient increase in procollagen propeptides in the CSF after subarachnoid hemorrhage. Neurology (2000) 0.92
Causes of death in pedigrees with the 3243A>G mutation in mitochondrial DNA. J Neurol Neurosurg Psychiatry (2008) 0.92
Familial aggregation of Parkinson's disease in a Finnish population. J Neurol Neurosurg Psychiatry (2000) 0.92
Prolyl 3-hydroxylase and 4-hydroxylase activities in certain rat and chick-embryo tissues and age-related changes in their activities in the rat. Biochem J (1979) 0.91
Hearing impairment in patients with 3243A-->G mtDNA mutation: phenotype and rate of progression. Hum Genet (2001) 0.91
Turnover of prolyl hydroxylase tetramers and the monomer-size protein in chick-embryo cartilaginous bone and lung in vivo. Biochem J (1979) 0.91
Complex segregation analysis of Parkinson's disease in the Finnish population. Hum Genet (2001) 0.90
Analysis of mitochondrial DNA sequences in patients with isolated or combined oxidative phosphorylation system deficiency. J Med Genet (2006) 0.89
Rapid induction of meningeal collagen synthesis in the cerebral cisternal and ventricular compartments after subarachnoid hemorrhage. Acta Neurochir (Wien) (2001) 0.88
Increase of collagen synthesis and deposition in the arachnoid and the dura following subarachnoid hemorrhage in the rat. Biochim Biophys Acta (1999) 0.88
Frequency of mitochondrial DNA point mutations among patients with familial sensorineural hearing impairment. Eur J Hum Genet (2000) 0.87
High concentrations of procollagen propeptides in chronic subdural haematoma and effusion. J Neurol Neurosurg Psychiatry (2003) 0.86
Mutations in EIF4G1 are not a common cause of Parkinson's disease. Eur J Neurol (2013) 0.85
Childhood encephalopathies and myopathies: a prospective study in a defined population to assess the frequency of mitochondrial disorders. Pediatrics (2000) 0.85
Increased activities of antioxidant enzymes and decreased ATP concentration in cultured myoblasts with the 3243A-->G mutation in mitochondrial DNA. Biochim Biophys Acta (2000) 0.85
Mutations in CHMP2B are not a cause of frontotemporal lobar degeneration in Finnish patients. Eur J Neurol (2010) 0.84
No association of the mitochondrial DNA A12308G polymorphism with increased risk of stroke in patients with the A3243G mutation. J Neurol Neurosurg Psychiatry (2004) 0.84
Relative fitness of carriers of the mitochondrial DNA mutation 3243A > G. Eur J Hum Genet (2001) 0.84
Low prevalence of progranulin mutations in Finnish patients with frontotemporal lobar degeneration. Eur J Neurol (2008) 0.83
Connective tissue metabolites in serum as markers of disease activity in patients with rheumatoid arthritis. Clin Exp Rheumatol (1988) 0.82
Synthesis of collagen: chemical regulation of post-translational events. Ciba Found Symp (1985) 0.80
Restriction fragment analysis as a source of error in detection of heteroplasmic mtDNA mutations. Mutat Res (1999) 0.80
Parkinsonism associated with the homozygous W748S mutation in the POLG1 gene. Parkinsonism Relat Disord (2008) 0.80
Mitochondrial DNA deletion diagnosed by analysis of an endomyocardial biopsy specimen from a patient with Kearns-Sayre syndrome and complete heart block. Br Heart J (1992) 0.79
Modifier locus for mitochondrial DNA disease: linkage and linkage disequilibrium mapping of a nuclear modifier gene for maternally inherited deafness. Genet Med (2001) 0.78
Ubiquinone and nicotinamide treatment of patients with the 3243A-->G mtDNA mutation. Neurology (2002) 0.78
Increased risk of sensorineural hearing loss and migraine in patients with a rare mitochondrial DNA variant 4336A>G in tRNAGln. J Med Genet (2001) 0.77
Haplotype-matched controls as a tool to discriminate polymorphisms from pathogenic mutations in mtDNA. Hum Genet (1999) 0.77
Voxelwise analysis of diffusion tensor imaging and structural MR imaging in patients with the m.3243A>G mutation in mitochondrial DNA. AJNR Am J Neuroradiol (2011) 0.76
Molecular genetic analysis of the alpha-synuclein and the parkin gene in Parkinson's disease in Finland. Eur J Neurol (2002) 0.76
Familial aggregation of cervical artery dissection and cerebral aneurysm. Stroke (1994) 0.76
Specific non-enzymatic glycation of the rat histone H1 nucleotide binding site in vitro in the presence of AlF4-. A putative mechanism for impaired chromatin function. Biochim Biophys Acta (1993) 0.76
Adult-onset diabetes mellitus and neurosensory hearing loss in maternal relatives of MELAS patients in a family with the tRNA(Leu(UUR)) mutation. Neurology (1993) 0.75
Variations of mitochondrial DNA polymerase γ in patients with Parkinson's disease. J Neurol (2013) 0.75
Regulation of proline 3-hydroxylation and prolyl 3-hydroxylase and 4-hydroxylase activities in transformed cells. Biochem J (1982) 0.75
Labelling of prolyl hydroxylase tetrameric subunits in freshly isolated chick-embryo tendon cells and in certain chick-embryo tissues in vivo. Biochem J (1982) 0.75
Effect of prevention of procollagen triple-helix formation on proline 3-hydroxylation in freshly isolated chick-embryo tendon cells. Biochem J (1981) 0.75
The Finnish speech-in-noise test in MELAS mutation and other sensorineural hearing impairments. Scand Audiol Suppl (2001) 0.75
Interference of AlF4- with nucleotide and DNA binding of rat histone H1 in vitro. Implications for the pathogenesis of Alzheimer's disease. Neurosci Lett (1991) 0.75
Kearns-Sayre syndrome case presenting a mitochondrial DNA deletion with unusual direct repeats and a rudimentary RNAase mitochondrial ribonucleotide processing target sequence. Genomics (1993) 0.75
Epidemiology of the mitochondrial DNA 8344A>G mutation for the myoclonus epilepsy and ragged red fibres (MERRF) syndrome. J Neurol Neurosurg Psychiatry (2003) 0.75